Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart failure (HF) would allow targeted intervention, and appears to be the most promising approach in its management. Novel biomarker panels may support this approach and provide new insights into the pathophysiology.status: publishe
New biomarkers are being evaluated for their ability to advance the management of patients with hear...
Heart failure (HF) is a complex clinical syndrome with a huge social burden in terms of cost, morbid...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart failure (HF) wo...
Background: Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart fai...
Diastolic heart failure (DHF) is characterized by slow left ventricular (LV) relaxation, increased L...
Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection...
Heart failure (HF) has a complex pathophysiology including neurohormonal activation, inflammation an...
In a previous cross-sectional study, we identified a multidimensional urinary classifier (HF1), whic...
Since natriuretic peptides were successfully integrated into the clinical practice of heart failure ...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
Since natriuretic peptides were successfully integrated into the clinical practice of heart failure ...
Biomarkers play an important role in heart failure. They provide us information about the mechanisms...
New biomarkers are being evaluated for their ability to advance the management of patients with hear...
Heart failure (HF) is a complex clinical syndrome with a huge social burden in terms of cost, morbid...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart failure (HF) wo...
Background: Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart fai...
Diastolic heart failure (DHF) is characterized by slow left ventricular (LV) relaxation, increased L...
Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection...
Heart failure (HF) has a complex pathophysiology including neurohormonal activation, inflammation an...
In a previous cross-sectional study, we identified a multidimensional urinary classifier (HF1), whic...
Since natriuretic peptides were successfully integrated into the clinical practice of heart failure ...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
Since natriuretic peptides were successfully integrated into the clinical practice of heart failure ...
Biomarkers play an important role in heart failure. They provide us information about the mechanisms...
New biomarkers are being evaluated for their ability to advance the management of patients with hear...
Heart failure (HF) is a complex clinical syndrome with a huge social burden in terms of cost, morbid...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....